共 50 条
- [35] WHO WILL BENEFIT FROM GRISEOFULVIN JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1964, 190 (02): : 149 - &
- [38] Rituximab for idiopathic membranous nephropathy: Who can benefit? CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (04): : 738 - 748